During the past decade, Triangle Neuropsychiatry conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Triangle Neuropsychiatry" #1 sponsor was "Shire" with 10 trials, followed by "Noven Therapeutics" with 2 trials sponsored, "Cephalon" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Sunovion" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Triangle Neuropsychiatry" are "ADHD" (4 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials), "Attention-Deficit/Hyperactivity Disorder" (2 trials), "ADHD Specifically With Executive Function Impairment" (1 trials) and "Adult Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Triangle Neuropsychiatry" in a lesser frequency.

Most popular intervention types in "Triangle Neuropsychiatry" are "Drug" (15 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Extended-release Guanfacine Hydrochloride" (2 trials), "SHP465" (2 trials), "Aripiprazole" (1 trials) and "Atomoxetine Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Triangle Neuropsychiatry" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Triangle Neuropsychiatry". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Triangle Neuropsychiatry, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Triangle Neuropsychiatry, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".